Pardes Biosciences, Inc.

Ownership Transactions Reported by 22 Insiders

Industry
Pharmaceutical Preparations
Location
2173 Salk Avenue, Suite 250, Pmb#052, Carlsbad, California

There are no Buy or Sell transactions made by insiders since 9/12/2023

Pardes Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foresite Capital Management V, LLC 10%+ Owner $20.4M Apr 5, 2023
Foresite Capital Opportunity Management V, LLC 10%+ Owner $13.2M Apr 5, 2023
FS Development Holdings II, LLC 10%+ Owner $7.31M Dec 23, 2021
James B. Tananbaum President and CEO, Director, 10%+ Owner $1.5K Aug 31, 2023
Uri A. Lopatin Director Aug 31, 2023
Michael David Varney Director Aug 31, 2023
Mark Auerbach Director Aug 31, 2023
Deborah M. Autor Director Aug 31, 2023
Daniel Dubin Director Dec 23, 2021
Brian Kearney Chief Development Officer Feb 1, 2023
Sean P. Brusky Chief Commercial Officer Feb 1, 2023
H. Lacy General Counsel, Secretary Aug 31, 2023
John C. Pottage Jr Director Aug 31, 2023
Owen Hughes Director Dec 23, 2021
Thomas G. Wiggans Chief Executive Officer, Director Aug 31, 2023
J. Jay Lobell Director Aug 31, 2023
Laurie Smaldone Director Aug 31, 2023
Brian Philippe Tinmouth Chief Bus. & Strategy Officer Sep 14, 2022
Laura Hamill Director Aug 31, 2023
Deepika Pakianathan Director Dec 23, 2021
Heidi Henson Chief Financial Officer Aug 31, 2023
Lee D. Arnold Chief Scientific Officer Feb 1, 2022

Recent Insider Transactions by Companies or Individuals for Pardes Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.